| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0008 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.001 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |